Current status and prospects of immunotherapy for locally advanced nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is a squamous cell carcinoma arising from the nasopharyngeal epithelium, which is associated with Epstein-Barr virus (EBV) infection and is most common in southern China. Immunotherapy, particularly immune checkpoint inhibitors (ICIs), provides favorable efficacy with...
Saved in:
| Main Authors: | LIU Xixi, SUN Yajie, YANG Kunyu |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Guangxi Medical University
2024-09-01
|
| Series: | Guangxi Yike Daxue xuebao |
| Subjects: | |
| Online Access: | https://journal.gxmu.edu.cn/article/doi/10.16190/j.cnki.45-1211/r.2024.09.009 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of camrelizumab in treatment of nasopharyngeal carcinoma
by: Yu. V. Alymov, et al.
Published: (2024-12-01) -
Familial clustering of nasopharyngeal carcinoma in the family of an adolescent with nasopharyngeal carcinoma
by: Buket Kara, et al.
Published: (2022-12-01) -
Nasopharyngeal Carcinoma in Children: Clinical Cases
by: Mark E. Prokofyev, et al.
Published: (2021-05-01) -
Toripalimab: A new age in fighting Nasopharyngeal Carcinoma
by: Taha Ahmad Siddiqui, et al.
Published: (2025-01-01) -
Bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapy
by: Gang Wang, et al.
Published: (2024-12-01)